Company Filing History:
2 out of 1,209 
2 out of 517 
2 out of 2,963 
Years Active: 2022-2025
Title: Innovations of Jessica Weaver
Introduction
Jessica Weaver is an accomplished inventor based in Brighton, MA (US). She has made significant contributions to the field of biomedical research, particularly in the area of cancer treatment. With a total of two patents to her name, her work focuses on innovative methods for modulating programmed death 1 (PD-1) signaling.
Latest Patents
Jessica's latest patents include a method of assessing the efficacy of a test agent for modulating PD-1 signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies. This invention is based on the discovery of monoclonal and polyclonal antibodies that specifically bind to phosphorylated PD-1. It also encompasses immunoglobulins, polypeptides, nucleic acids, and methods for using such antibodies for diagnostic, prognostic, and therapeutic purposes. Another notable patent is for anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, which includes methods of making and using these antibodies for similar applications.
Career Highlights
Throughout her career, Jessica has worked with prestigious institutions such as Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. Her research has been pivotal in advancing the understanding of cancer therapies and improving patient outcomes.
Collaborations
Jessica has collaborated with esteemed colleagues, including Gordon James Freeman and Vassiliki A. Boussiotis. These partnerships have further enhanced her research and contributed to the success of her inventions.
Conclusion
Jessica Weaver's innovative work in the field of cancer research exemplifies the impact of dedicated inventors on medical science. Her patents reflect a commitment to improving therapeutic strategies and advancing healthcare solutions.